Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2003
12/02/2003US6656966 Nitrosated and nitrosylated taxanes, compositions and methods of use
12/02/2003US6656964 Reducing levels of tumor necrosis factor alpha; inhibition of undesireable levels of matrix metalloproteinases
12/02/2003US6656963 Indole-3-carbinol (I3C) derivatives and methods
12/02/2003US6656962 Use of amino-isoxazolidone compounds for improvement of lexical priming
12/02/2003US6656961 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
12/02/2003US6656960 Administering drug to produce cardiac asystole upon stimulation of one or both vagus nerves; inserting an electrode into esophagus of patient; actuating electrode to create an electrical field effective to stimulate vagus nerve
12/02/2003US6656959 PDE IV inhibiting pyridine derivatives
12/02/2003US6656958 Substituted pyridine compounds useful for controlling chemical synaptic transmission
12/02/2003US6656957 Pyridine derivatives
12/02/2003US6656955 Side effect reduction; synergistic mixture
12/02/2003US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
12/02/2003US6656945 6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-one cGMP-PDE inhibitors for the treatment of erectile dysfunction
12/02/2003US6656943 1-phenyl-4-benzlpiperazines: dopamine receptor subtype specific ligands
12/02/2003US6656942 Orally active salts with tyrosine kinase activity
12/02/2003US6656941 Altering the signal-transducing activity of GABAA receptors; diagnosis and treatment of anxiety, depression, Down Syndrome, sleep and seizure disorders
12/02/2003US6656939 Pyrazole compounds useful as protein kinase inhibitors
12/02/2003US6656938 Inducing cytokine biosynthesis in animals, for the treatment of diseases, including viral and neoplastic diseases
12/02/2003US6656937 Substituted glutarimides and their use as inhibitors of IL-12 production
12/02/2003US6656936 Growth inhibitors of Candida albicans, and anti-HIV agents
12/02/2003US6656935 Aromatic nitrogen-containing 6-membered cyclic compounds
12/02/2003US6656934 2-amino-benzoxazinone derivatives for the treatment of obesity
12/02/2003US6656933 Novel compounds which inhibit production of cytokines involved in inflammatory processes
12/02/2003US6656932 Treating osteoarthritis, rheumatoid arthritis, cancer, inflammation, and heart failure
12/02/2003US6656931 Vasopressin antagonist and diuretic combination
12/02/2003US6656930 Aralkyl diazabicycloalkane derivatives for CNS disorders
12/02/2003US6656929 Pharmaceutical composition with a synthetic natural progesterone and oestradiol base and its preparation process
12/02/2003US6656928 Comprising a corticosteroid, a broad spectrum anti-fungal agent that treats both dermatophytes and yeast, and a drying agent selected from the group consisting of calamine, zinc containing drying agents, copper sulfate, kaolin, etc.
12/02/2003US6656924 Immunopotentiating compositions
12/02/2003US6656922 Oral delivery of macromolecules
12/02/2003US6656921 Use of zinc hyaluronate for the prevention of reinfection after the healing of peptic ulcer by Helicobacter pylori
12/02/2003US6656920 Administering a disaccharide such as maltose or trehalose, optionally along with Vitamin C or a derivative, to increase saliva excretion; treating Sjogren's syndrome and xerostomia
12/02/2003US6656919 Method and a product for the rapid decontamination and sterilization of bacterial endospores
12/02/2003US6656915 Inhibiting T-cell proliferation
12/02/2003US6656914 Method for treating tumors caused by APC gene mutation with anthocyanins and cyanidin
12/02/2003US6656913 Including enterotoxins, Toxic Shock Syndrome Toxin-1 ("TSST-1") and enzymes such as protease and lipase from S. aureus found in the vagina; vaginal cleaning compound comprising alkyl polyglycoside inhibits production
12/02/2003US6656912 Liver and respiratory system disorders
12/02/2003US6656907 Method of treating gastric ulcer by administration of epidermal growth factor
12/02/2003US6656904 Inhibitors of proteasomal activity for stimulating bone and hair growth
12/02/2003US6656734 Compositions for the delivery of polynucleotides to cells
12/02/2003US6656730 Attached to an arylpropionic acid that interacts with human serum albumin; acid is ibuprofen, suprofen, ketoprofen, (S)-(+)- pranoprofen, or carprofen.
12/02/2003US6656720 For use in vaccines
12/02/2003US6656713 Compounds and methods for modulating activation of NF-κB
12/02/2003US6656711 Fermentative preparation process for and crystal forms of cytostatics
12/02/2003US6656706 Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes
12/02/2003US6656704 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
12/02/2003US6656681 Polycystic kidney disease 12 gene and uses thereof
12/02/2003US6656517 Therapeutic, diagnostic, or hydrophilic coating for an intracorporeal medical device
12/02/2003US6656510 Antidepressants
12/02/2003US6656509 Synergistic
12/02/2003US6656503 Counters ulcerogenic side effects; nonsteroidal antiinflam-matory core with polymer and misoprostol coating
12/02/2003US6656502 Sustained-release prostaglandin I derivative preparation
12/02/2003US6656500 For delivery of water insoluble active retinoid agents comprising a vehicle for initially dissolving the active agent, emulsifier and capsule shell formulated to open in the gastrointestinal tract
12/02/2003US6656482 Spill resistant pharmaceutical system
12/02/2003US6656475 Modulating growth of muscle or adipose tissue in eukaryotic organism using agent that affects myostatin signal transduction
12/02/2003US6656473 Defatted meal from squash seeds containing protein-bound tryptophan and carbohydrate source (glucose, maltose, sucrose) for facilitating transport across the blood brain barrier; useful for inducing sleep
12/02/2003US6656471 Monitoring HLA-Cw7-restricted CTL response; AIDS prevention
12/02/2003US6656460 Method and composition for dry eye treatment
12/02/2003US6656459 Compositions of non-ionic block copolymers to treat autoimmune and inflammatory diseases, and to reduce graft/implantation, and methods of use thereof
12/02/2003US6656458 Strengthening and caring for hair with alkyldihydroxyamino derivative of polyn-methylglycine
12/02/2003US6656453 Aerosol formulation comprising particulate salbutamol sulphate having a crystalline form in which the outer layer of the crystals is nonamorphous and 1,1,1,2-tetrafluoroethane; for treating respiratory disorders
12/02/2003US6656452 Use of inhaled NO as anti-inflammatory agent
12/02/2003US6656385 Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
12/02/2003US6656172 Method for treating severe tinnitus
12/02/2003CA2287046C Novel dihydroquinoline and tetrahydroquinoline compounds, process for preparing them and pharmaceutical compositions containing them
12/02/2003CA2284446C New cyclic cycloalkylene chain derivatives, their preparation process and pharmaceutical compounds containing them
12/02/2003CA2258920C Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies
12/02/2003CA2254061C Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
12/02/2003CA2249756C New indanol compounds, their preparation process and the pharmaceutical compositions containing them
12/02/2003CA2248317C Anticonvulsant enantiomeric amino acid derivatives
12/02/2003CA2244785C Pentafluorobenzenesulfonamides and analogs
12/02/2003CA2224284C Use of 19-nor-vitamin d compounds for the prevention of hyperphosphatemia in kidney disorder patients
12/02/2003CA2132865C Transdermal administration of oxybutynin
12/02/2003CA2118007C Phosphonic diester derivative
12/02/2003CA2085171C Guanidinoalkyl-1, 1-bisphosphonic acid derivatives, process for their preparation and their use
12/02/2003CA2075201C Use of an .alpha.-tocopherol phosphate or a derivative thereof for preparing cosmetic, dermatological or pharmaceutical compositions, and compositions thereby obtained
11/2003
11/30/2003CA2388659A1 Phospholipase a2 expression and activity and use thereof for diagnosis, prognostication, prevention and treatment of neural inflammatory and demyelinating disease
11/30/2003CA2388456A1 Macroaggregated albumin-polyethyleneimine (maa-pei) lung-targeted delivery of respiratory syncytial virus dna vaccines
11/29/2003WO2003096988A2 Tr4/tr2 response elements
11/29/2003CA2486351A1 Tr4/tr2 response elements
11/27/2003WO2003098385A2 System and method for transparent early detection, warning, and intervention during a medical procedure
11/27/2003WO2003098223A2 A method for killing cells by inhibiting histone activity in the cell
11/27/2003WO2003097862A1 Method of searching substane having antidiabetic activity
11/27/2003WO2003097855A2 Small molecule inhibitors of her2 expression
11/27/2003WO2003097849A1 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor
11/27/2003WO2003097835A2 Pharmaceutical compositions for the treatment of cancer
11/27/2003WO2003097820A1 Method of utilizing physiological activity of rare saccharide and compositions containing rare saccharide
11/27/2003WO2003097806A2 Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/27/2003WO2003097805A2 Delivery of nucleic acid-like compounds
11/27/2003WO2003097799A2 HTLV-I TAX INDUCED KILLING OF p53 NULL CANCER CELLS
11/27/2003WO2003097714A1 Fat binding using inter-polymer complex of glucosamine and polyacrylic acid
11/27/2003WO2003097698A1 Treatment of cancer by the use of anti fas antibody
11/27/2003WO2003097696A1 Methods and copositions for the treatment of ischemic reperfusion
11/27/2003WO2003097659A1 6-11 bicyclic ketolide derivatives
11/27/2003WO2003097658A2 Compounds and methods for inhibiting selectin-mediated function
11/27/2003WO2003097657A1 An antimicrobial agent
11/27/2003WO2003097656A2 Novel substituted sulfamate anticonvulsant derivatives
11/27/2003WO2003097649A2 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
11/27/2003WO2003097648A1 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the prepartion thereof
11/27/2003WO2003097647A1 Vitamin-mitomycin conjugates
11/27/2003WO2003097646A1 Acyl bicyclix derivatives of pyrrol
1 ... 5258 5259 5260 5261 5262 5263 5264 5265 5266 5267 5268 5269 5270 5271 5272 5273 5274 5275 5276 5277 5278 ... 7860